Kymera Therapeutics listed on the stock exchange and filed required disclosures with the SEC on June 22, 2026.
2 reports, 2 independent
Updated Jun 26
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Kymera Therapeutics listed on the stock exchange and filed required disclosures with the SEC on June 22, 2026.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Analyst raised price target on Kymera stock.1 source
Kymera Therapeutics debuted on Nasdaq and filed necessary disclosures with the SEC.1 source
Keep exploring
Part of
The new event is a collection of disparate items reported on June 22, 2026, including a share debut on Nasdaq, talks between the U.S. and Iran affecting oil prices, and market commentary involving tech players like Google and SpaceX.Also in this story
- Semiconductor suppliers Qualcomm and Lam Research, along with Google, are noted as major technology stocks on Nasdaq.
- An IPO raised $86 billion in recent weeks, with listing ADRs up to $29 billion, amidst geopolitical factors like the war causing oil prices to spike.
- S&P and Fitch Ratings evaluated the creditworthiness of SpaceX.
- AIxCrypto is a Nasdaq-listed company operating in Chicago.
The entities involved
-
Kymera Therapeutics
biopharmaceutical company
Nothing else this week.
-
Nasdaq
American fully electronic stock exchange
-
SEC
Slovak company